Mesoblast completes Phase 3 low back pain trial treatment as pivotal readout approaches
Mesoblast has completed treatment of 350 patients in its pivotal Phase 3 trial for chronic low back pain, with results expected in mid-2027.
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| MLI | Appendix 3B | 23/04/18 | ||
| MLI | Final Director's Interest Notice | 23/04/18 | ||
| MLI | Final Director's Interest Notice | 23/04/18 | ||
| MLI | Initial Director's Interest Notice | 23/04/18 | ||
| MLI | Initial Director's Interest Notice | 23/04/18 | ||
| MLI | Change of Director's Interest Notice | 23/04/18 | ||
| MLI | Change of Director's Interest Notice | 23/04/18 | ||
| MLI | Change of Director's Interest Notice | 23/04/18 | ||
| MLI | Re-Listing Update | 17/04/18 | ||
| MLI | Prospectus Offer Closed | 10/04/18 | ||
| MLI | Investor Presentation | 20/03/18 | ||
| MLI | Extension of Automatic De-Listing Date | 19/03/18 | ||
| MLI | Results of General Meeting | 16/03/18 | ||
| MLI | Timetable Extension | 15/03/18 | ||
| MLI | Correction to Notice of Meeting | 07/03/18 | ||
| MLI | Prospectus | PRICE SENSITIVE | 16/02/18 | |
| MLI Appendix 3B | |||
| 23/04/18 | |||
| MLI Final Director's Interest Notice | |||
| 23/04/18 | |||
| MLI Final Director's Interest Notice | |||
| 23/04/18 | |||
| MLI Initial Director's Interest Notice | |||
| 23/04/18 | |||
| MLI Initial Director's Interest Notice | |||
| 23/04/18 | |||
| MLI Change of Director's Interest Notice | |||
| 23/04/18 | |||
| MLI Change of Director's Interest Notice | |||
| 23/04/18 | |||
| MLI Change of Director's Interest Notice | |||
| 23/04/18 | |||
| MLI Re-Listing Update | |||
| 17/04/18 | |||
| MLI Prospectus Offer Closed | |||
| 10/04/18 | |||
| MLI Investor Presentation | |||
| 20/03/18 | |||
| MLI Extension of Automatic De-Listing Date | |||
| 19/03/18 | |||
| MLI Results of General Meeting | |||
| 16/03/18 | |||
| MLI Timetable Extension | |||
| 15/03/18 | |||
| MLI Correction to Notice of Meeting | |||
| 07/03/18 | |||
| MLI Prospectus | |||
| 16/02/18 | PRICE SENSITIVE | ||
